159 related articles for article (PubMed ID: 18286512)
1. Is there an optimal comorbidity index for prostate cancer?
Alibhai SM; Leach M; Tomlinson GA; Krahn MD; Fleshner NE; Naglie G
Cancer; 2008 Mar; 112(5):1043-50. PubMed ID: 18286512
[TBL] [Abstract][Full Text] [Related]
2. Is there age bias in the treatment of localized prostate carcinoma?
Alibhai SM; Krahn MD; Cohen MM; Fleshner NE; Tomlinson GA; Naglie G
Cancer; 2004 Jan; 100(1):72-81. PubMed ID: 14692026
[TBL] [Abstract][Full Text] [Related]
3. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent.
Boulos DL; Groome PA; Brundage MD; Siemens DR; Mackillop WJ; Heaton JP; Schulze KM; Rohland SL
Cancer; 2006 Apr; 106(8):1804-14. PubMed ID: 16534794
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
5. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
[TBL] [Abstract][Full Text] [Related]
6. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
[TBL] [Abstract][Full Text] [Related]
8. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
Alibhai SM; Leach M; Warde P
Cancer; 2009 Jan; 115(2):293-302. PubMed ID: 19025976
[TBL] [Abstract][Full Text] [Related]
9. Do older men benefit from curative therapy of localized prostate cancer?
Alibhai SM; Naglie G; Nam R; Trachtenberg J; Krahn MD
J Clin Oncol; 2003 Sep; 21(17):3318-27. PubMed ID: 12947068
[TBL] [Abstract][Full Text] [Related]
10. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Jeldres C; Suardi N; Walz J; Saad F; Hutterer GC; Bhojani N; Shariat SF; Perrotte P; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol; 2008 Jul; 54(1):107-16. PubMed ID: 17996358
[TBL] [Abstract][Full Text] [Related]
11. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Walz J; Gallina A; Saad F; Montorsi F; Perrotte P; Shariat SF; Jeldres C; Graefen M; Bénard F; McCormack M; Valiquette L; Karakiewicz PI
J Clin Oncol; 2007 Aug; 25(24):3576-81. PubMed ID: 17704404
[TBL] [Abstract][Full Text] [Related]
12. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M
Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities.
Tewari A; Johnson CC; Divine G; Crawford ED; Gamito EJ; Demers R; Menon M
J Urol; 2004 Apr; 171(4):1513-9. PubMed ID: 15017210
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
[TBL] [Abstract][Full Text] [Related]
15. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
16. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
[TBL] [Abstract][Full Text] [Related]
17. Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.
Groome PA; Rohland SL; Siemens DR; Brundage MD; Heaton J; Mackillop WJ
Cancer; 2011 Sep; 117(17):3943-52. PubMed ID: 21858801
[TBL] [Abstract][Full Text] [Related]
18. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
Walz J; Gallina A; Perrotte P; Jeldres C; Trinh QD; Hutterer GC; Traumann M; Ramirez A; Shariat SF; McCormack M; Perreault JP; Bénard F; Valiquette L; Saad F; Karakiewicz PI
BJU Int; 2007 Dec; 100(6):1254-8. PubMed ID: 17979925
[TBL] [Abstract][Full Text] [Related]
19. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
Sun L; Caire AA; Robertson CN; George DJ; Polascik TJ; Maloney KE; Walther PJ; Stackhouse DA; Lack BD; Albala DM; Moul JW
J Urol; 2009 Nov; 182(5):2242-8. PubMed ID: 19758616
[TBL] [Abstract][Full Text] [Related]
20. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
Pfitzenmaier J; Pritsch M; Haferkamp A; Jakobi H; Fritsch F; Gilfrich C; Djakovic N; Buse S; Pahernik S; Hohenfellner M
BJU Int; 2009 Apr; 103(7):877-82. PubMed ID: 19007372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
